Zentek Past Earnings Performance

Past criteria checks 0/6

Zentek's earnings have been declining at an average annual rate of -45.2%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 44.9% per year.

Key information

-45.2%

Earnings growth rate

-41.3%

EPS growth rate

Medical Equipment Industry Growth-19.2%
Revenue growth rate44.9%
Return on equity-53.3%
Net Margin-35,637.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09
Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31
Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11
We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26
We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Revenue & Expenses Breakdown
Beta

How Zentek makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:ZEN Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-1292
30 Sep 230-13102
30 Jun 230-13101
31 Mar 230-14112
31 Dec 220-36132
30 Sep 220-35122
30 Jun 220-35112
31 Mar 220-32102
31 Dec 210-861
30 Sep 210-861
30 Jun 210-550
31 Mar 210-440
31 Dec 200-440
30 Sep 200-220
30 Jun 200-220
31 Mar 200-220
31 Dec 190-220
30 Sep 190-220
30 Jun 190-320
31 Mar 190-220
31 Dec 180-220
30 Sep 180-220
30 Jun 180-110
31 Mar 180-220
31 Dec 170-220
30 Sep 170-220
30 Jun 170-330
31 Mar 170-330
31 Dec 160-330
30 Sep 160-330
30 Jun 160-330
31 Mar 160-440
31 Dec 150-440
30 Sep 150-440
30 Jun 150-440
31 Mar 150-330
31 Dec 140-330
30 Sep 140-330
30 Jun 140-330
31 Mar 140-430
31 Dec 130-440
30 Sep 130-330

Quality Earnings: ZEN is currently unprofitable.

Growing Profit Margin: ZEN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZEN is unprofitable, and losses have increased over the past 5 years at a rate of 45.2% per year.

Accelerating Growth: Unable to compare ZEN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZEN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: ZEN has a negative Return on Equity (-53.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.